Mediplus Ltd

Mediplus Seeks Distribution Partners

Mediplus seeks distribution partners for its unique range of urology, urodynamic and anaesthetics (TIVA) products

Mediplus was established in the United Kingdom in 1986. The Company’s focus is the research, development, manufacture and marketing of innovative medical devices that meet the needs of patients and clinicians worldwide.
The Mediplus philosophy is to provide high quality products at fair prices supported by excellence in customer service. The Company sells direct to end-users in the United Kingdom and to more than forty countries internationally through a network of carefully selected distributors.

Mediplus is a medical devices innovation company. Since 1986 company successes include:

· Launch of the world’s first non-invasive pressure flow system - the CT3000. The CT3000 is a device that measures bladder pressure in men non-invasively and it is used to screen patients who have Lower Urinary Tract Symptoms. In the UK each year 26000 men undergo an operation on the prostate to relieve Bladder Outlet Obstruction. Currently, only 70% of these patients benefit from the surgery. Many of the 30% of men who see little change in symptoms following surgery have poor bladder contractility. The CT3000 is a simple test that identifies those patients that will benefit from surgery. Clinical trials demonstrate that the success rate of the operation increases to 90% following screening by CT3000.

· Development and launch of Siamese tubing and colour coding in the anaesthetic TIVA range to prevent entanglement and deliver increased patient safety through reduction in medication errors.

· Development of the Mediplus Suprapubic Catheter system; an easier and safer method of introducing a Foley catheter suprapubically. This product does not require general anaesthetic and is therefore in demand from hospitals who wish to deliver high quality care at lower cost.

The above products have the ability to change the way in which patients are diagnosed, treated and managed to not only significantly improve quality of life but also save millions of dollars for healthcare systems around the world. The United Kingdom’s NHS has published a significant amount of data on Mediplus products stating that they are cost effective and beneficial to patients.

Mediplus is seeking good quality distributors to bring these products to a worldwide stage. We would be delighted to meet with you to discuss how we could work together to help patients benefit from the Mediplus product range. We look forward to seeing you Hall 16 / G04-4 on the ABHI Pavilion.